Spots Global Cancer Trial Database for stage ib melanoma
Every month we try and update this database with for stage ib melanoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Studying Tumor Tissue Samples From Patients With Melanoma Who Have Undergone Sentinel Lymph Node Biopsy | NCT00897481 | Melanoma (Skin) | gene expression... mutation analys... diagnostic labo... immunohistochem... sentinel lymph ... | - | National Cancer Institute (NCI) | |
| Studying Tumor Tissue Samples From Patients With Melanoma Who Have Undergone Sentinel Lymph Node Biopsy | NCT00897481 | Melanoma (Skin) | gene expression... mutation analys... diagnostic labo... immunohistochem... sentinel lymph ... | - | National Cancer Institute (NCI) | |
| Vaccine Therapy in Treating HLA-A2 Positive Patients With Melanoma | NCT00003895 | Recurrent Melan... Stage IA Melano... Stage IB Melano... Stage IIA Melan... Stage IIB Melan... Stage IIC Melan... Stage IIIA Mela... Stage IIIB Mela... Stage IIIC Mela... | HPV 16 E7:12-20 gp100:209-217(2... laboratory biom... | 17 Years - | National Cancer Institute (NCI) | |
| Comparing Follow-Up Schedules in Patients With Newly Diagnosed Stage IB or Stage II Melanoma | NCT01018004 | Melanoma (Skin) | follow-up care questionnaire a... quality-of-life... | 18 Years - 85 Years | National Cancer Institute (NCI) | |
| Sargramostim or Hypertonic Saline Before Sentinel Lymph Node Biopsy in Treating Patients With Stage IB-II Melanoma | NCT01826864 | Stage IB Melano... Stage IIA Melan... Stage IIB Melan... Stage IIC Melan... | sargramostim sentinel lymph ... laboratory biom... hypertonic sali... | 18 Years - 75 Years | Jonsson Comprehensive Cancer Center | |
| Sargramostim or Hypertonic Saline Before Sentinel Lymph Node Biopsy in Treating Patients With Stage IB-II Melanoma | NCT01826864 | Stage IB Melano... Stage IIA Melan... Stage IIB Melan... Stage IIC Melan... | sargramostim sentinel lymph ... laboratory biom... hypertonic sali... | 18 Years - 75 Years | Jonsson Comprehensive Cancer Center | |
| Comparing Follow-Up Schedules in Patients With Newly Diagnosed Stage IB or Stage II Melanoma | NCT01018004 | Melanoma (Skin) | follow-up care questionnaire a... quality-of-life... | 18 Years - 85 Years | National Cancer Institute (NCI) | |
| Comparing Follow-Up Schedules in Patients With Newly Diagnosed Stage IB or Stage II Melanoma | NCT01018004 | Melanoma (Skin) | follow-up care questionnaire a... quality-of-life... | 18 Years - 85 Years | National Cancer Institute (NCI) | |
| Studying Tumor Tissue Samples From Patients With Melanoma Who Have Undergone Sentinel Lymph Node Biopsy | NCT00897481 | Melanoma (Skin) | gene expression... mutation analys... diagnostic labo... immunohistochem... sentinel lymph ... | - | National Cancer Institute (NCI) | |
| Study of Families With Melanoma | NCT00445783 | Melanoma (Skin) | gene expression... mutation analys... immunohistochem... laboratory biom... examination mutation carrie... study of high r... | 18 Years - | National Cancer Institute (NCI) | |
| Comparing Follow-Up Schedules in Patients With Newly Diagnosed Stage IB or Stage II Melanoma | NCT01018004 | Melanoma (Skin) | follow-up care questionnaire a... quality-of-life... | 18 Years - 85 Years | National Cancer Institute (NCI) | |
| Answering Questions About Vitamin D Supplementation and Sun Exposure in Patients Who Have Undergone Surgery for Stage IB, Stage II, or Stage IIIA Melanoma | NCT00672321 | Melanoma (Skin) | gene expression... mutation analys... polymorphism an... laboratory biom... questionnaire a... | - | National Cancer Institute (NCI) | |
| Vaccine Therapy in Treating HLA-A2 Positive Patients With Melanoma | NCT00003895 | Recurrent Melan... Stage IA Melano... Stage IB Melano... Stage IIA Melan... Stage IIB Melan... Stage IIC Melan... Stage IIIA Mela... Stage IIIB Mela... Stage IIIC Mela... | HPV 16 E7:12-20 gp100:209-217(2... laboratory biom... | 17 Years - | National Cancer Institute (NCI) | |
| Identifying Gene Mutations in Patients With Melanoma and in Families With a History of Hereditary Melanoma | NCT00450593 | Hereditary Mult... Melanoma (Skin) | gene expression... microarray anal... molecular genet... mutation analys... laboratory biom... mutation carrie... study of high r... | - | National Cancer Institute (NCI) | |
| Biomarkers to Predict Response to Interferon Therapy in Patients With Melanoma | NCT00897546 | Melanoma (Skin) | laboratory biom... | 18 Years - 120 Years | Eastern Cooperative Oncology Group |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
